Metabolon, Stemina resolve patent dispute; cancer experts criticize Canada's 'patchwork' genetic testing system;

> Research Triangle Park, NC-based Metabolon has settled a patent dispute with Stemina Biomarker Discovery over its technology. The two companies resolved the dispute by forging a licensing deal. Story

> Cancer experts are critical of Canada's "patchwork" system for testing patients for genetic markers that will flag the likelihood of responding to new drugs. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.